Glucagon-Like Peptide-1 Analogs Associated With a Reduced Risk of Legal Blindness in Type 2 Diabetics With Cardiovascular Risks

CTSA https://www.dovepress.com/glucagon-like-peptide-1-analogs-associated-with-a-reduced-risk-of-lega-peer-reviewed-fulltext-article-OPTH 2026-02-03T00:00:00Z Clinical Ophthalmology